Home/Filings/4/0001562180-22-000296
4//SEC Filing

Hinton Bryan Richard 4

Accession 0001562180-22-000296

CIK 0001636422other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:28 PM ET

Size

8.9 KB

Accession

0001562180-22-000296

Insider Transaction Report

Form 4
Period: 2022-01-03
Hinton Bryan Richard
Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-03$10.78/sh+106$1,1439,481 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-03106423 total
    Exercise: $10.78Exp: 2028-05-03Common Stock (106 underlying)
  • Sale

    Common Stock

    2022-01-03$39.76/sh106$4,2159,375 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 3, 2021, in accordance with Rule 10b5-1.
  • [F2]25% of the 5,082 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on May 3, 2022.

Issuer

Health Catalyst, Inc.

CIK 0001636422

Entity typeother

Related Parties

1
  • filerCIK 0001855244

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:28 PM ET
Size
8.9 KB